Cargando…
Everolimus (RAD001) in the Treatment of Advanced Renal Cell Carcinoma: A Review
Historically, there have been few treatment options for patients with advanced renal cell carcinoma (RCC) besides immunotherapy with interleukin-2 and interferon (IFN)-α. Targeted therapies have improved clinical outcomes over the past several years. These include the vascular endothelial growth fac...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AlphaMed Press
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3227953/ https://www.ncbi.nlm.nih.gov/pubmed/20215359 http://dx.doi.org/10.1634/theoncologist.2009-0141 |